200 related articles for article (PubMed ID: 30706680)
21. Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (2) Invasive Diagnostic Testing for Fetal Chromosomal Abnormalities.
Lee JY; Kwon JY; Na S; Choe SA; Seol HJ; Kim M; Kim MA; Park CW; Kim K; Ryu HM; Hwang HS; Shim JY
J Korean Med Sci; 2021 Jan; 36(4):e26. PubMed ID: 33496085
[TBL] [Abstract][Full Text] [Related]
22. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
[TBL] [Abstract][Full Text] [Related]
23. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?
Mennuti MT; Cherry AM; Morrissette JJ; Dugoff L
Am J Obstet Gynecol; 2013 Nov; 209(5):415-9. PubMed ID: 23529082
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic testing after positive results on cell free DNA screening: CVS or Amnio?
Mardy AH; Norton ME
Prenat Diagn; 2021 Sep; 41(10):1249-1254. PubMed ID: 34386984
[TBL] [Abstract][Full Text] [Related]
25. Contribution of maternal mosaicism to false-positive chromosome X loss associated with noninvasive prenatal testing.
Wan J; Li R; Li F; Yu Q; Wang D; Sun X; Zhang Y; Jing X; Tang X; Chen G; Jiang F; Li F; Fu F; Li Y; Zhang L; Yi C; Li J; Li D; Liao C
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9647-9653. PubMed ID: 35282756
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
27. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
Gray KJ; Wilkins-Haug LE
Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
[TBL] [Abstract][Full Text] [Related]
28. The significance of trisomy 7 mosaicism in noninvasive prenatal screening.
Qi Y; Yang J; Hou Y; Guo F; Peng H; Wang D; Du Q; Yin A
Hum Genomics; 2019 Apr; 13(1):18. PubMed ID: 30971315
[TBL] [Abstract][Full Text] [Related]
29. Rare autosomal trisomies: comparison of detection through cell-free DNA analysis and direct chromosome preparation of chorionic villus samples.
Benn P; Malvestiti F; Grimi B; Maggi F; Simoni G; Grati FR
Ultrasound Obstet Gynecol; 2019 Oct; 54(4):458-467. PubMed ID: 31237735
[TBL] [Abstract][Full Text] [Related]
30. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
31. Prenatal diagnosis of uniparental disomy 15 following trisomy 15 mosaicism.
Christian SL; Smith AC; Macha M; Black SH; Elder FF; Johnson JM; Resta RG; Surti U; Suslak L; Verp MS; Ledbetter DH
Prenat Diagn; 1996 Apr; 16(4):323-32. PubMed ID: 8734806
[TBL] [Abstract][Full Text] [Related]
32. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
[TBL] [Abstract][Full Text] [Related]
33. Sequencing Shorter cfDNA Fragments Decreases the False Negative Rate of Non-invasive Prenatal Testing.
Xue Y; Zhao G; Qiao L; Lu J; Yu B; Wang T
Front Genet; 2020; 11():280. PubMed ID: 32273885
[TBL] [Abstract][Full Text] [Related]
34. [Value of non-invasive prenatal testing for rare autosomal trisomies in fetuses].
Xie X; Zhao Q; Hu L; Jiang S; Wang X; Zhang W; Li Z; You Y; Lu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Dec; 43(12):2071-2077. PubMed ID: 38189393
[TBL] [Abstract][Full Text] [Related]
35. Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling.
Feresin A; Stampalija T; Cappellani S; Bussani R; Faletra F; Murru F; Ulivi S; Suergiu S; Savarese P; Pedicini A; Policicchio M; Ruggiero R; Bosio B; Savarese G; Ardisia C
Front Genet; 2022; 13():982508. PubMed ID: 36386832
[TBL] [Abstract][Full Text] [Related]
36. Multicenter clinical experience with non-invasive cell-free DNA screening for monosomy X and related X-chromosome variants.
Bedei I; Gehrke T; Gloning KP; Meyer-Wittkopf M; Willner D; Krapp M; Scharf A; Degenhardt J; Heling KS; Kozlowski P; Trautmann K; Jahns KM; Geipel A; Baumüller JE; Wilhelm L; Gottschalk I; Schröer A; Graf A; Wolter A; Schenk J; Weber A; Van den Veyver IB; Axt-Fliedner R
Prenat Diagn; 2023 Feb; 43(2):192-206. PubMed ID: 36726284
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive prenatal testing: the future is now.
Norwitz ER; Levy B
Rev Obstet Gynecol; 2013; 6(2):48-62. PubMed ID: 24466384
[TBL] [Abstract][Full Text] [Related]
38. Cell-free DNA screening for fetal aneuploidy as a clinical service.
Cuckle H; Benn P; Pergament E
Clin Biochem; 2015 Oct; 48(15):932-41. PubMed ID: 25732593
[TBL] [Abstract][Full Text] [Related]
39. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
40. Use of noninvasive prenatal screening with cell-free DNA in late pregnancy with sonographic soft markers.
Wan JH; Zhen L; Han J; Pan M; Yang X; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():431-433. PubMed ID: 32721841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
